Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-006484
Filing Date
2019-03-08
Accepted
2019-03-08 16:41:01
Documents
2
Period of Report
2019-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 5737
2 lsloanpoa.htm EX-24 5929
  Complete submission text file 0001567619-19-006484.txt   13118
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250 AUSTIN TX 78746
Business Address
Sloan Leslie (Reporting) CIK: 0001719455 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 19669648